These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 32371361

  • 1. Generation of RUNX1-null reporter human embryonic stem cell line GIBHe008-A.
    Ullah H, You H, Shah Z, Fan C, Zhang B, Liu H, Zhang J, Abbas N, Filonenko ES, Samokhvalov IM.
    Stem Cell Res; 2020 May; 45():101800. PubMed ID: 32371361
    [Abstract] [Full Text] [Related]

  • 2. RUNX1-205, a novel splice variant of the human RUNX1 gene, has blockage effect on mesoderm-hemogenesis transition and promotion effect during the late stage of hematopoiesis.
    Sun W, Zeng J, Chang J, Xue Y, Zhang Y, Pan X, Zhou Y, Lai M, Bian G, Zhou Q, Liu J, Chen B, Ma F.
    J Mol Cell Biol; 2020 Jun 11; 12(5):386-396. PubMed ID: 32313936
    [Abstract] [Full Text] [Related]

  • 3. A role for RUNX1 in hematopoiesis and myeloid leukemia.
    Ichikawa M, Yoshimi A, Nakagawa M, Nishimoto N, Watanabe-Okochi N, Kurokawa M.
    Int J Hematol; 2013 Jun 11; 97(6):726-34. PubMed ID: 23613270
    [Abstract] [Full Text] [Related]

  • 4. The differential activities of Runx1 promoters define milestones during embryonic hematopoiesis.
    Sroczynska P, Lancrin C, Kouskoff V, Lacaud G.
    Blood; 2009 Dec 17; 114(26):5279-89. PubMed ID: 19858498
    [Abstract] [Full Text] [Related]

  • 5. Runx1/AML1 in normal and abnormal hematopoiesis.
    Yamagata T, Maki K, Mitani K.
    Int J Hematol; 2005 Jul 17; 82(1):1-8. PubMed ID: 16105753
    [Abstract] [Full Text] [Related]

  • 6. Multifunctional reversible knockout/reporter system enabling fully functional reconstitution of the AML1/Runx1 locus and rescue of hematopoiesis.
    Samokhvalov IM, Thomson AM, Lalancette C, Liakhovitskaia A, Ure J, Medvinsky A.
    Genesis; 2006 Mar 17; 44(3):115-21. PubMed ID: 16496309
    [Abstract] [Full Text] [Related]

  • 7. Inability of RUNX1/AML1 to breach AML1-ETO block of embryonic stem cell definitive hematopoiesis.
    Peterson LF, Lo MC, Okumura AJ, Zhang DE.
    Blood Cells Mol Dis; 2007 Mar 17; 39(3):321-8. PubMed ID: 17692541
    [Abstract] [Full Text] [Related]

  • 8. Inducible overexpression of RUNX1b/c in human embryonic stem cells blocks early hematopoiesis from mesoderm.
    Chen B, Teng J, Liu H, Pan X, Zhou Y, Huang S, Lai M, Bian G, Mao B, Sun W, Zhou Q, Yang S, Nakahata T, Ma F.
    J Mol Cell Biol; 2017 Aug 01; 9(4):262-273. PubMed ID: 28992293
    [Abstract] [Full Text] [Related]

  • 9. Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia.
    Ganly P, Walker LC, Morris CM.
    Leuk Lymphoma; 2004 Jan 01; 45(1):1-10. PubMed ID: 15061191
    [Abstract] [Full Text] [Related]

  • 10. Runx1 isoforms show differential expression patterns during hematopoietic development but have similar functional effects in adult hematopoietic stem cells.
    Challen GA, Goodell MA.
    Exp Hematol; 2010 May 01; 38(5):403-16. PubMed ID: 20206228
    [Abstract] [Full Text] [Related]

  • 11. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.
    Li X, Vradii D, Gutierrez S, Lian JB, van Wijnen AJ, Stein JL, Stein GS, Javed A.
    J Cell Biochem; 2005 Nov 01; 96(4):795-809. PubMed ID: 16149049
    [Abstract] [Full Text] [Related]

  • 12. A germline point mutation in Runx1 uncouples its role in definitive hematopoiesis from differentiation.
    Dowdy CR, Frederick D, Zaidi SK, Colby JL, Lian JB, van Wijnen AJ, Gerstein RM, Stein JL, Stein GS.
    Exp Hematol; 2013 Nov 01; 41(11):980-991.e1. PubMed ID: 23823022
    [Abstract] [Full Text] [Related]

  • 13. Expression of AML/Runx and ETO/MTG family members during hematopoietic differentiation of embryonic stem cells.
    Okumura AJ, Peterson LF, Lo MC, Zhang DE.
    Exp Hematol; 2007 Jun 01; 35(6):978-88. PubMed ID: 17533052
    [Abstract] [Full Text] [Related]

  • 14. The role of Runx1/AML1 and Evi-1 in the regulation of hematopoietic stem cells.
    Kumano K, Kurokawa M.
    J Cell Physiol; 2010 Feb 01; 222(2):282-5. PubMed ID: 19847803
    [Abstract] [Full Text] [Related]

  • 15. Developmentally regulated promoter-switch transcriptionally controls Runx1 function during embryonic hematopoiesis.
    Pozner A, Lotem J, Xiao C, Goldenberg D, Brenner O, Negreanu V, Levanon D, Groner Y.
    BMC Dev Biol; 2007 Jul 12; 7():84. PubMed ID: 17626615
    [Abstract] [Full Text] [Related]

  • 16. Increase of hematopoietic progenitor and suppression of endothelial gene expression by Runx1 expression during in vitro ES differentiation.
    Sakai E, Kitajima K, Sato A, Nakano T.
    Exp Hematol; 2009 Mar 12; 37(3):334-45. PubMed ID: 19218012
    [Abstract] [Full Text] [Related]

  • 17. Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia.
    Antony-Debré I, Manchev VT, Balayn N, Bluteau D, Tomowiak C, Legrand C, Langlois T, Bawa O, Tosca L, Tachdjian G, Leheup B, Debili N, Plo I, Mills JA, French DL, Weiss MJ, Solary E, Favier R, Vainchenker W, Raslova H.
    Blood; 2015 Feb 05; 125(6):930-40. PubMed ID: 25490895
    [Abstract] [Full Text] [Related]

  • 18. Transient RUNX1 Expression during Early Mesendodermal Differentiation of hESCs Promotes Epithelial to Mesenchymal Transition through TGFB2 Signaling.
    VanOudenhove JJ, Medina R, Ghule PN, Lian JB, Stein JL, Zaidi SK, Stein GS.
    Stem Cell Reports; 2016 Nov 08; 7(5):884-896. PubMed ID: 27720906
    [Abstract] [Full Text] [Related]

  • 19. AML1/Runx1 negatively regulates quiescent hematopoietic stem cells in adult hematopoiesis.
    Ichikawa M, Goyama S, Asai T, Kawazu M, Nakagawa M, Takeshita M, Chiba S, Ogawa S, Kurokawa M.
    J Immunol; 2008 Apr 01; 180(7):4402-8. PubMed ID: 18354160
    [Abstract] [Full Text] [Related]

  • 20. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
    Maicas M, Vázquez I, Vicente C, García-Sánchez MA, Marcotegui N, Urquiza L, Calasanz MJ, Odero MD.
    Oncogene; 2013 Apr 18; 32(16):2069-78. PubMed ID: 22689058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.